Medacta Group Equity 2024

Medacta Group Aktienanalyse

What does Medacta Group do?

The Medacta Group SA is a leading global company in the development, manufacturing, and marketing of medical devices and implants for the orthopedic industry. The company was founded in 1999 by Swiss entrepreneur Alberto Siccardi and is headquartered in Switzerland. The Medacta Group SA has its origins in one person - Alberto Siccardi. As a former athlete and successful entrepreneur, he had a vision that he put into action. He founded the Medacta Group and began focusing on the development and manufacturing of innovative orthopedic devices and implants. The Medacta Group has an innovative business model because the company is able to handle everything from research and development to marketing and sales of its products. This means that Medacta combines all steps from idea to end product under one roof and has complete control over the entire process. The Medacta Group SA is divided into three business areas: orthopedics, spine, and sports medicine. In the orthopedic field, the company manufactures hip and knee joint implants, as well as shoulder and elbow implants. Medacta also offers technologies that help extend the lifespan of artificial joints. In the spine field, the company provides instruments and implants for spine surgery. Medacta has a high level of expertise in this field and is known for innovative products that contribute to improving patient treatment. In the sports medicine field, the Medacta Group offers solutions for sports injuries. The company has developed a wide range of technologies and products that accelerate the healing process and support rehabilitation. Some of Medacta's most well-known products are the AMIS (Anterior Minimally Invasive Surgery) hip joint system and the GMK (General Medacta Knee) knee joint system. The AMIS system is a minimally invasive procedure for hip joint surgery that aims to shorten rehabilitation time and reduce the risk of complications. The GMK system is an innovative knee joint system that allows natural joint mechanics and approximates the natural knee pivot point. Medacta has also developed a range of software solutions that support surgeons in the planning and execution of operations. These solutions provide detailed visualizations and allow for precise planning of procedures. In conclusion, the Medacta Group SA is a global leader in the development and manufacturing of medical devices and implants for orthopedics, spine, and sports medicine. The company has an innovative business model that allows for complete control of the entire manufacturing process. Through the development of innovative products and technologies, the Medacta Group supports the treatment and rehabilitation of patients worldwide. Medacta Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Medacta Group's Equity

Medacta Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Medacta Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Medacta Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Medacta Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Medacta Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Medacta Group stock

What is the equity of Medacta Group this year?

Medacta Group has equity of 330.04 M EUR this year.

What was the equity of Medacta Group compared to the previous year?

The equity of Medacta Group has increased/decreased by 20.16% increased compared to the previous year.

What impact does a high equity have on investors of Medacta Group?

A high equity is advantageous for investors of Medacta Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Medacta Group?

A low equity can be a risk for investors of Medacta Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Medacta Group affect the company?

An increase in equity of Medacta Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Medacta Group affect the company?

A reduction in equity of Medacta Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Medacta Group?

Some factors that can affect the equity of Medacta Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Medacta Group so important for investors?

The equity of Medacta Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Medacta Group take to change the equity?

To change equity, Medacta Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Medacta Group pay?

Over the past 12 months, Medacta Group paid a dividend of 0.27 EUR . This corresponds to a dividend yield of about 0.22 %. For the coming 12 months, Medacta Group is expected to pay a dividend of 0.31 EUR.

What is the dividend yield of Medacta Group?

The current dividend yield of Medacta Group is 0.22 %.

When does Medacta Group pay dividends?

Medacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medacta Group?

Medacta Group paid dividends every year for the past 0 years.

What is the dividend of Medacta Group?

For the upcoming 12 months, dividends amounting to 0.31 EUR are expected. This corresponds to a dividend yield of 0.26 %.

In which sector is Medacta Group located?

Medacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medacta Group from 5/14/2024 amounting to 0.275 EUR, you needed to have the stock in your portfolio before the ex-date on 5/10/2024.

When did Medacta Group pay the last dividend?

The last dividend was paid out on 5/14/2024.

What was the dividend of Medacta Group in the year 2023?

In the year 2023, Medacta Group distributed 0.268 EUR as dividends.

In which currency does Medacta Group pay out the dividend?

The dividends of Medacta Group are distributed in EUR.